low density lipoprotein receptor
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of gene expression | ||
| positive regulation of triglyceride biosynthetic process | ||
| regulation of phosphatidylcholine catabolic process | ||
| negative regulation of low-density lipoprotein particle clearance | ||
| phospholipid transport |
| GO Term | Evidence Code | PMID |
|---|---|---|
| lysosome | ||
| early endosome | ||
| early endosome | ||
| late endosome | ||
| Golgi apparatus |
| GO Term | Evidence Code | PMID |
|---|---|---|
| amyloid-beta binding | ||
| virus receptor activity | ||
| protease binding | ||
| low-density lipoprotein particle receptor activity | ||
| low-density lipoprotein particle receptor activity |
| Gene Ontology |
|---|
| calcium ion binding |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:10652 | Alzheimer's disease | |
| DOID:12783 | migraine without aura | |
| DOID:13810 | familial hypercholesterolemia | |
| DOID:1883 | hepatitis C | |
| DOID:2349 | arteriosclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025